Evidence map›Paper›PMID 42192957›Full record

ArticleCancers2026

Total Neoadjuvant Approach for Borderline Resectable and Locally Advanced Pancreatic Adenocarcinoma-UK Tertiary Cancer Centre Experience.

Kai Tai Derek Yeung, Simon Gomberg, William Hodgson, Petula Jefferies, David Cunningham, Sheela Rao, Ian Chau, Naureen Starling, Charlotte Fribbens, Avani Athauda and 8 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancers, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Kai Tai Derek YeungRoyal Marsden Hospital, London SW3 6JJ, UK.ORCID 0000-0002-5679-9435
Simon GombergRoyal Marsden Hospital, London SW3 6JJ, UK.
William HodgsonRoyal Marsden Hospital, London SW3 6JJ, UK.
Petula JefferiesRoyal Marsden Hospital, London SW3 6JJ, UK.
David CunninghamRoyal Marsden Hospital, London SW3 6JJ, UK.ORCID 0000-0001-5158-1069
Sheela RaoRoyal Marsden Hospital, London SW3 6JJ, UK.
Ian ChauRoyal Marsden Hospital, London SW3 6JJ, UK.ORCID 0000-0003-0286-8703
Naureen StarlingRoyal Marsden Hospital, London SW3 6JJ, UK.ORCID 0000-0002-1496-6792
Charlotte FribbensRoyal Marsden Hospital, London SW3 6JJ, UK.
Avani AthaudaRoyal Marsden Hospital, London SW3 6JJ, UK.ORCID 0000-0001-9366-7899
Diana TaitRoyal Marsden Hospital, London SW3 6JJ, UK.ORCID 0000-0001-5808-1200
Irene ChongRoyal Marsden Hospital, London SW3 6JJ, UK.
Arabella HuntRoyal Marsden Hospital, London SW3 6JJ, UK.ORCID 0009-0003-4232-5890
Magnus T DillonRoyal Marsden Hospital, London SW3 6JJ, UK.ORCID 0000-0001-5136-5227
Sacheen KumarRoyal Marsden Hospital, London SW3 6JJ, UK.ORCID 0000-0002-4692-4554
Long R JiaoRoyal Marsden Hospital, London SW3 6JJ, UK.
Ricky H BhogalRoyal Marsden Hospital, London SW3 6JJ, UK.
Katharine AitkenRoyal Marsden Hospital, London SW3 6JJ, UK.ORCID 0000-0002-2942-3678

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

chemoradiationneoadjuvant treatmentpancreatic adenocarcinoma

Identifiers

PMID42192957
PMCPMC13205041

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.